Format

Send to

Choose Destination
Haematologica. 2015 Oct;100(10):e428-31. doi: 10.3324/haematol.2015.127373. Epub 2015 Jun 18.

Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice.

Author information

1
CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France Université Paris 7, France.
2
CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Department of Biochemistry, Faculty of Medicine Siriraj Hospital and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
3
Division of Pediatric Hematology/Oncology, Children's Hospital Boston, and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
4
CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France.
5
CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm U967 - CEA / DSV / IRCM, Fontenay Aux Roses Cedex, France.
6
Hôpital Antoine Béclère, Service d'Histologie Embryologie Cytogénétique, "Assistance Publique - Hôpitaux de Paris", Clamart, France.
7
Bluebirdbio, Cambridge, MA, USA.
8
Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Department of Biochemistry, Faculty of Medicine Siriraj Hospital and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
9
CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France.
10
CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Genetics Division, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.
11
CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France leila.maouche@inserm.fr.

KEYWORDS:

Engraftment of cy-iPSC-derived hematopoietic cells; Induced pluripotent stem cells; Nonhuman primate

PMID:
26088930
PMCID:
PMC4591782
DOI:
10.3324/haematol.2015.127373
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center